cyclocreatine has been researched along with Cell Transformation, Neoplastic in 2 studies
cyclocreatine: structure given in first source
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurmi, K | 1 |
Hitosugi, S | 1 |
Yu, J | 1 |
Boakye-Agyeman, F | 1 |
Wiese, EK | 1 |
Larson, TR | 1 |
Dai, Q | 1 |
Machida, YJ | 1 |
Lou, Z | 1 |
Wang, L | 1 |
Boughey, JC | 1 |
Kaufmann, SH | 1 |
Goetz, MP | 1 |
Karnitz, LM | 1 |
Hitosugi, T | 1 |
Lillie, JW | 1 |
O'Keefe, M | 1 |
Valinski, H | 1 |
Hamlin, HA | 1 |
Varban, ML | 1 |
Kaddurah-Daouk, R | 1 |
2 other studies available for cyclocreatine and Cell Transformation, Neoplastic
Article | Year |
---|---|
Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ce | 2018 |
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Transformation, Neoplastic; Creatine | 1993 |